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ABSTRACT
The American College of Cardiology (ACC) participated in
a joint project with the American Society of Echocardi-
ography, the Society of Pediatric Echocardiography, and
several other subspecialty societies and organizations to
establish and evaluate Appropriate Use Criteria (AUC) for
the initial use of outpatient pediatric echocardiography.
Assumptions for the AUC were identiﬁed, including the
fact that all indications assumed a ﬁrst-time transthoracic
echocardiographic study in an outpatient setting for pa-
tients without previously known heart disease. The deﬁ-
nitions for frequently used terminology in outpatient
pediatric cardiology were established using published
guidelines and standards and expert opinion. These AUC
serve as a guide to help clinicians in the care of children
with possible heart disease, speciﬁcally in terms of when
a transthoracic echocardiogram is warranted as an initial
diagnostic modality in the outpatient setting. They are
also a useful tool for education and provide the
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2041infrastructure for future quality improvement initiatives
as well as research in healthcare delivery, outcomes, and
resource utilization.
To complete the AUC process, the writing group iden-
tiﬁed 113 indications based on common clinical scenarios
and/or published clinical practice guidelines, and each
indication was classiﬁed into 1 of 9 categories of common
clinical presentations, including palpitations, syncope,
chest pain, and murmur. A separate, independent rating
panel evaluated each indication using a scoring scale of 1
to 9, thereby designating each indication as “Appropriate”
(median score 7 to 9), “May Be Appropriate” (median score
4 to 6), or “Rarely Appropriate” (median score 1 to 3).
Fifty-three indications were identiﬁed as Appropriate, 28
as May Be Appropriate, and 32 as Rarely Appropriate.
PREFACE
In an effort to respond to the need for the rational use of
services in the delivery of high quality care, the ACC has
undertaken a process to determine the appropriate use of
cardiovascular imaging and procedures for selected pa-
tient indications.
AUC publications reﬂect an ongoing effort by the ACC
to critically and systematically create, review, and cate-
gorize clinical situations where diagnostic tests and pro-
cedures are utilized by physicians caring for patients with
known or suspected cardiovascular diseases. The process
is based on current understanding of the technical capa-
bilities of the imaging modalities and procedures exam-
ined. Although not intended to be entirely comprehensive
due to the wide diversity of clinical disease, the in-
dications are meant to identify common scenarios
encountered by the majority of contemporary practices.
Given the breadth of information they convey, the in-
dications do not directly correspond to the International
Classiﬁcation of Diseases (ICD) system.
The ACC believes that careful blending of a broad range
of clinical experiences and available evidence-based infor-
mation will help guide a more efﬁcient and equitable allo-
cation of health care resources in cardiovascular imaging.
The ultimate objective of AUC is to improve patient care
and health outcomes in a cost-effective manner, but they
are not intended to ignore ambiguity and nuance intrinsic
to clinical decision-making. Local parameters, such as the
availability or quality of equipment or personnel, may in-
ﬂuence the selection of certain tests or procedures. AUC
thus should not be considered substitutes for sound clinical
judgment and practice experience.
1. INTRODUCTION
Improvements in cardiovascular imaging technologies
and their application, particularly with increasing thera-
peutic options for cardiovascular disease, have led to anincrease in the utilization of such technologies. As these
imaging technologies and clinical applications continue to
advance, the healthcare community needs to understand
how best to incorporate these options into daily clinical
care and how to choose between new and long-standing,
established imaging technologies. In an effort to res-
pond to this need and to ensure the effective use of
advanced diagnostic imaging tools and procedures, the
AUC project was initiated. The AUC in this document have
been developed in order to promote effective patient
care, better clinical outcomes, and improved resource
utilization. This set of AUC should be useful not only for
pediatric cardiologists, but also for general pediatricians
and family practitioners, who are frequently the ﬁrst cli-
nicians to consider the need for this modality.
Although AUC have been established for echocardiog-
raphy in adult patients (1–3), a similar document for pe-
diatric patients has not yet been published. This is partly
because the scope of such a document would require an
impossibly extensive list, if criteria were developed for
each congenital cardiac malformation and its variants
before and after intervention. Guidelines and standards
for performing a pediatric echocardiogram, as well as
recommendations for quantiﬁcation methods, have
already been published (4,5). However, the questions
often raised by AUC of “when to do” and “how often to
do” a pediatric echocardiogram still remained.
To address these concerns, the American College of
Cardiology initiated an AUC document on pediatric
echocardiography in the outpatient setting, since outpa-
tient care is an important component of clinical pediatric
cardiology. Children with heart disease represent a widely
varied group of patients, frequently characterized by
complex anatomic malformations requiring lifelong
follow-up. While echocardiography is the primary diag-
nostic modality for children with established congenital
and acquired heart disease, the scope of the current
document has been limited to ﬁrst-time outpatient
transthoracic echocardiographic studies in patients
without previously known cardiac abnormalities. This
narrower set of clinical presentations has been chosen
because of the high volume of such testing within pedi-
atric cardiology. In addition, this initiative has established
the infrastructure to develop additional AUC for pediatric
and congenital echocardiography in other settings.
2. METHODS
This document covers a wide array of potential signs
and symptoms associated with cardiovascular disease in
pediatric patients. A standardized approach was used to
create different categories of indications with the goal of
capturing actual clinical scenarios, without making the list
of indications excessively long. Indications were created
1Negative consequences include the risks of the procedure (i.e., radiation or
contrast exposure) and the downstream impact of poor test performance such as
delay in diagnosis (false negatives) or inappropriate diagnosis (false positives).
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2042to represent most of the possible uses of echocardiography
in the outpatient pediatric setting rather than limiting the
AUC to indications for which evidence was available.
To identify and categorize the indications, a writing
group of pediatric echocardiography experts was formed
of representatives from a variety of organizations and
societies. Wherever possible during the writing process,
the group members would map the indications to rele-
vant clinical guidelines and key publications or refer-
ences (See Online Appendix). Once the indications were
formed, they were reviewed and critiqued by the parent
AUC Task Force and numerous external reviewers repre-
senting all pediatric cardiovascular specialties and pri-
mary care. After the writing group incorporated this
initial feedback, the indications were sent to an inde-
pendent rating panel comprised of additional experts in
the pediatrics and pediatric cardiology realm, before be-
ing sent back to the writing group for additional vetting.
Each indication was then rated and classiﬁed as either
“Appropriate care”, “May Be Appropriate care”, or
“Rarely Appropriate care” based on these multiple rounds
of review and revision (see Figure 1).
A detailed description of themethods used for rating the
selected clinical indications is found in a previous publi-
cation, “ACCF Proposed Method for Evaluating the
Appropriateness of Cardiovascular Imaging,” (6) as well as
the updated version, “Appropriate Use of Cardiovascular
Technology: 2013 ACCF Appropriate Use Criteria
Methodology Update: A Report of the American College
of Cardiology Foundation Appropriate Use Criteria Task
Force” (7). Brieﬂy, this process combines evidence-based
medicine and practice experience and engages a rating
panel in a modiﬁed Delphi exercise. Other steps are
convening a formal writing group with diverse expertise
in pediatric imaging and clinical care, circulating the
indications for external review prior to being sent to the
rating panel, ensuring an appropriate balance of
expertise and practice areas among the rating panelists,
developing a standardized rating package that includes
relevant evidence, and establishing formal roles for
facilitating panel interaction at the face-to-face meeting.
The rating panel ﬁrst evaluated the indications inde-
pendently. Then, the panel was convened for a face-to-face
meeting for discussion of each indication. At this meeting,
panel members were given their scores and a blinded
summary of their peers’ scores. After the meeting, panel
members were then asked to independently provide their
ﬁnal scores for each indication (See Online Appendix).
Although panel members were not provided explicit
cost information to help determine their appropriate use
ratings, they were asked to implicitly consider cost as an
additional factor in their evaluation of appropriate use. In
rating these criteria, the AUC Rating Panel was asked to
assess whether the use of the test for each indicationshould be categorized as Appropriate care, May Be
Appropriate care, or Rarely Appropriate care, and was
provided the following deﬁnition of appropriate use:
An appropriate imaging study is one in which the ex-
pected incremental information, combined with clinical
judgment, exceeds the expected negative consequences1
by a sufﬁciently wide margin for a speciﬁc indication
that the procedure is generally considered acceptable
care and a reasonable approach for the indication.
The rating panel scored each indication as follows:
Median Score 7 to 9: Appropriate test for speciﬁc indi-
cation (test is generally acceptable and is a reasonable
approach for the indication).
An appropriate option for management of patients in this
population due to beneﬁts generally outweighing risks;
effective option for individual care plans although not
always necessary depending on physician judgment and
patient speciﬁc preferences (i.e., procedure is generally
acceptable and is generally reasonable for the indication).
Median Score 4 to 6:May Be Appropriate test for speciﬁc
indication (test may be generally acceptable and may be a
reasonable approach for the indication). May Be Appro-
priate also implies that more research and/or patient in-
formation is needed to classify the indication deﬁnitively.
At times an appropriate option for management of pa-
tients in this population due to variable evidence or lack of
agreement regarding the beneﬁts risks ratio, potential
beneﬁt based on practice experience in the absence of evi-
dence, and/or variability in the population; effectiveness
for individual care must be determined by a patient’s
physician in consultation with the patient based on addi-
tional clinical variables and judgment along with patient
preferences (i.e., procedure may be acceptable and may be
reasonable for the indication).
Median Score 1 to 3: Rarely Appropriate test for speciﬁc
indication (test is not generally acceptable and is not a
reasonable approach for the indication).
Rarely an appropriate option for management of
patients in this population due to the lack of a clear beneﬁt/
risk advantage; rarely an effective option for individual
care plans; exceptions should have documentation of the
clinical reasons for proceeding with this care option
(i.e., procedure is not generally acceptable and is not
generally reasonable for the indication).
The division of the numerical scores into 3 levels of
appropriateness is somewhat arbitrary and the numeric
designations should be viewed as existing on a contin-
uum. Further, there may be diversity in clinical opinion
for particular clinical scenarios, such that scores in the
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2043intermediate level of appropriate use should be labeled
“May Be Appropriate,” as critical patient or research data
may be lacking or discordant. This designation should be
a prompt to the ﬁeld to carry out deﬁnitive research
investigation whenever possible. It is anticipated that the
AUC reports will continue to be revised as further data are
generated and information from criteria implementation
is accumulated.
To prevent bias in the scoring process, the rating panel,
by design, included a minority of specialists in pediatric
echocardiography. Specialists, while offering important
clinical and technical insights, might have a natural ten-
dency to rate the indications within their specialty as more
appropriate than non-specialists. In addition, care was
taken to provide objective, nonbiased information, in-
cluding guidelines and key references, to the rating panel.
The level of agreement among panelists was analyzed
based on the RAND Corporation’s BIOMED Concerted
Action on Appropriateness rule (8) for a panel of 14 to
16 members. As such, agreement was deﬁned as an
indication where 4 or fewer panelists’ ratings fell outside
the 3-point region containing the median score.
Disagreement was deﬁned as occurring when at least 5
panelists’ ratings fell in both the Appropriate and the
Rarely Appropriate categories. Any indication having
disagreement was categorized as May Be Appropriate
regardless of the ﬁnal median score.3. GENERAL ASSUMPTIONS
1. This document will address the initial use of outpa-
tient transthoracic echocardiography (TTE) during
pediatric (# 18 years of age) outpatient care. Although
TTE is also an essential tool in hospitalized patients,
discussion of indications for this use is beyond the
scope of this document.
2. This AUC document will not address the use of TTE in
patients with previously known structural, functional,
or primary electrical cardiac abnormalities.
3. A comprehensive TTE examination may include 2-
dimensional, M-mode, and 3-dimensional imaging as
well as spectral and color Doppler evaluation, all of
which are important elements (9–11) to evaluate rele-
vant cardiac structures and hemodynamics. A
comprehensive TTE report includes interpretation of
all aspects of the TTE.
4. The use of transesophageal or stress echocardiogra-
phy will not be addressed in this document.
5. This document assumes that any other more deﬁni-
tive diagnostic test, including but not limited to
electrocardiogram (ECG), chest X-ray, or genetic
testing, when appropriate will be considered prior to
ordering a TTE.
6. All standard TTE techniques for image acquisition are
available for each indication and have a sensitivity
Patient Patient
Selection
Image
Acquisition
Image
Interpretation
Imaging Process
Laboratory Structure
Results
Communication
Improved
Patient Care
(Outcomes)
FIGURE 2 Factors Inﬂuencing Outcomes of an Imaging Study (16)
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literature.
7. The test is performed and interpreted by qualiﬁed
individual(s) in a facility that is in compliance with
national standards for performing pediatric echocar-
diograms (4).
8. AUC is one aspect of quality for imaging procedures
occurring at the time of patient selection. Several
additional factors should be addressed to support
high-quality results (see Figure 2). These other factors
are important but are not covered in this document.
9. The range of potential indications for echocardiogra-
phy is quite large, particularly in comparison with
other cardiovascular imaging tests. Thus, the in-
dications are, at times, purposefully broad to cover an
array of cardiovascular signs and symptoms and to
account for the ordering physician’s best judgment as
to the presence of cardiovascular abnormalities.
Additionally, there are likely clinical scenarios that
are not covered in this document.
10. A qualiﬁed clinician has obtained a complete clinical
history and performed the physical examination such
that the clinical status of the patient can be assumed
to be valid as stated in the indication (e.g., an
asymptomatic patient is truly asymptomatic for the
condition in question and sufﬁcient questioning of
the patient has been undertaken).
11. Some indications address whether or not an ECG
has been obtained and whether or not it reveals
any abnormalities as inﬂuencing the appropriateness
of additional echocardiographic assessment. It is
beyond the scope of this document to deﬁne every
possible clinical scenario involving speciﬁc ECG
abnormalities. Therefore, the term “abnormal ECG”
refers to only clinically pertinent ECG ﬁndings.
Criteria for “abnormal ECG” will be based upon stan-
dard published ECG normal values in pediatric pa-
tients (12–15).12. If the reason for a test can be assigned to more than
one indication, it is classiﬁed under the most clinically
signiﬁcant indication.
13. The term family history in this document refers to
ﬁrst-degree relatives only.
14. Cost is considered implicitly in the appropriate use
determination. Clinical beneﬁts should always be
considered ﬁrst, and costs should be considered in
relationship to these beneﬁts in order to better convey
net value. For example, a procedure with moderate
clinical efﬁcacy for a given AUC indication should not
be scored as more appropriate than a procedure with
high clinical efﬁcacy solely due to its lower cost. When
scientiﬁc evidence exists to support clinical beneﬁt,
cost efﬁciency and cost effectiveness should be
considered for any indication.
15. For each indication, the rating reﬂects whether
the echocardiogram is reasonable for the patient ac-
cording to the appropriate use deﬁnition, not whether
the test is preferred over another modality. It is not
assumed that the decision to perform a diagnostic test
has already been made. The level of appropriateness
also does not consider issues of local availability or
skill for any modality.
16. The category of May Be Appropriate is used when
insufﬁcient data are available for a deﬁnitive catego-
rization or when there is substantial disagreement
regarding the appropriateness of that indication. The
designation May Be Appropriate should not be used as
grounds for denial of reimbursement.
17. This manuscript does not address whether a cardiol-
ogy consultation is required prior to the echocardio-
gram unless speciﬁed in the indication.
4. DEFINITIONS
Abnormal electrocardiogram (ECG): Electrocardiographic
ﬁndings regarded as probably or deﬁnitely abnormal
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2045according to age as well as clinically signiﬁcant, and
including but not limited to ventricular hypertrophy,
atrial enlargement, complete bundle branch block, atrio-
ventricular block, prolonged QTc, abnormal T waves or
ST-T wave segments, Wolff-Parkinson-White syndrome,
premature atrial contractions (PACs), premature ventric-
ular contractions (PVCs), supraventricular tachycardia,
ventricular tachycardia, and Brugada syndrome
Arrhythmia: Documented irregular and/or abnormal
heart rate or rhythm (Patients with palpitations do not
necessarily have an arrhythmia, and patients with an
arrhythmia do not necessarily experience palpitations)
Cardiomyopathy: Disease affecting the structure and/or
function of the myocardium, including but not limited to
hypertrophic, dilated, or restrictive cardiomyopathy, left
ventricular non-compaction, or arrhythmogenic right
ventricular cardiomyopathy
Channelopathy: A clinical syndrome involving a genetic
mutation or acquired malfunction of the proteins forming
the myocardial ion channels (including but not limited to
Naþ, Kþ, and Ca2þ) of the cardiovascular electrical sys-
tem, including but not limited to long QT syndrome, short
QT syndrome, catecholaminergic polymorphic ventricular
tachycardia, and Brugada syndrome
Chest pain: Physical discomfort in the anterior thoracic
region
Congestive heart failure: A condition in which the heart
is unable to pump enough blood to meet the body’s
metabolic demands
Cyanosis: Bluish discoloration of the skin and mucous
membranes
Desaturation: For pediatric patients other than new-
borns, an oxygen saturation <95% as measured by pulse
oximeter; for newborns $24 hours of age, an oxygen
saturation that is (a) <90% in the initial screen or in repeat
screens, (b) <95% in the right hand and foot on 3 mea-
sures, each separated by 1 hour, or (c) a >3% absolute
difference in oxygen saturation between the right hand
and foot on 3 measures, each separated by 1 hour (17)
Echogenic focus: Small bright spot(s) frequently seen on
a fetal echocardiogram, usually related to the ventricular
papillary muscles and chordae and generally considered a
benign ﬁnding
Hypertension: Average systolic and/or diastolic blood
pressure that is $95th percentile for gender, age, and
height on 3 or more occasions
Murmur: Additional heart or vascular sound due to
normal or abnormal turbulent blood ﬂow heard during
auscultationInnocent murmur: Murmur that is consistent with
normal blood ﬂow and is determined not to be
related to any structural abnormalities of the heart or
great vessels, including but not limited to Still’smurmur, pulmonary ﬂow murmur, physiologic pe-
ripheral pulmonary stenosis, supraclavicular arterial
bruit, and venous hum; most innocent murmurs are
soft (less than or equal to grade 2/6), heard in early
systole, characterized as crescendo-decrescendo
type, and may vary with position
Pathologic murmur: Murmur that is suggestive of the
presence of a cardiovascular abnormality (not clearly
innocent sounding), including but not limited to
diastolic murmurs, holosystolic murmurs, late sys-
tolic murmurs, grade 3/6 systolic murmur or louder,
continuousmurmurs other than venous hums, harsh
murmurs, and murmurs that are provoked or be-
come louder with changes in position (from squat-
ting to standing) or during the strain phase of a
Valsalva maneuverNeonate: A child that is less than or equal to 28 days old
Neurocardiogenic syncope: A type of syncope typically
occurring in the upright position, in which the triggering
of a neural reﬂex results in a usually self-limited episode
of systemic hypotension and/or bradycardia or asystole
Palpitations: An unpleasant sensation of rapid, irreg-
ular, and/or forceful beating of the heart
Pre-Syncope: A state of experiencing lightheadedness,
dizziness, weakness, visual changes (such as spots, tunnel
vision, or loss of vision), auditory changes (ringing,
buzzing, or mufﬂed hearing), or feeling hot or cold
without loss of consciousness
Syncope: Sudden temporary loss of consciousness asso-
ciated with a loss of postural tone and with spontaneous
recovery that does not require electrical or chemical
cardioversion
5. ABBREVIATIONS
AUC ¼ Appropriate Use Criteria
ECG ¼ electrocardiogram
PAC ¼ premature atrial contraction
PVC ¼ premature ventricular contraction
TTE ¼ transthoracic echocardiogram
6. RESULTS
The ﬁnal ratings for pediatric echocardiography are listed
by indication in Tables 1 to 9. The ﬁnal score for each
indication reﬂects the median score of the 15 Rating
Panel members and has been labeled according to the
categories of Appropriate (median 7 to 9), May Be
Appropriate (median 4 to 6), or Rarely Appropriate (me-
dian 1 to 3). In the tables, the ﬁnal score for each indi-
cation is shown in parentheses with the ratings. Out of
113 total indications, 53 were considered Appropriate
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and 32 were considered Rarely Appropriate (28%). To see
the indications listed by Appropriate Use rating, see the
Online Appendix. The Discussion section highlights
further trends in scoring.
Figures 3, 4, 5, and 6 illustrate ﬂow diagrams based on
common patient symptoms (chest pain, syncope, palpi-
tations and arrhythmias, and murmur) that the clinician
can use to narrow down patient information until theTABLE 1 Palpitations and Arrhythmias
Indication
Palpitati
1. Palpitations with no other symptoms or signs of cardiovascular dise
2. Palpitations with no other symptoms or signs of cardiovascular dise
3. Palpitations with abnormal ECG
4. Palpitations with family history of a channelopathy
5. Palpitations in a patient with known channelopathy
6. Palpitations with family history at a young age (before the age of 5
and/or pacemaker or implantable deﬁbrillator placement
7. Palpitations with family history of cardiomyopathy
8. Palpitations in a patient with known cardiomyopathy
ECG Find
9. PACs in the prenatal or neonatal period
10. PACs after the neonatal period
11. Supraventricular tachycardia
12. PVCs in the prenatal or neonatal period
13. PVCs after the neonatal period
14. Ventricular tachycardia
15. Sinus bradycardia
16. Sinus arrhythmia
The number in parentheses next to the rating reﬂects the median score for that indication
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG
tricular contractions.
TABLE 2 Syncope
Indication
17. Syncope with or without palpitations and with no recent ECG
18. Syncope with no other symptoms or signs of cardiovascular diseas
19. Syncope with abnormal ECG
20. Syncope with family history of channelopathy
21. Syncope with family history at a young age (before the age of 50
pacemaker or implantable deﬁbrillator placement
22. Syncope with family history of cardiomyopathy
23. Probable neurocardiogenic (vasovagal) syncope
24. Unexplained pre-syncope
25. Exertional syncope
26. Unexplained post-exertional syncope
27. Syncope or pre-syncope with a known non-cardiovascular cause
The number in parenthesis next to the rating reﬂects the median score for that indication
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECGAUC score is attained. Likewise, Figure 7 (a-d) in the
Online Appendix shows ﬂow diagrams grouped by clin-
ical presentation, such as family history and test
ﬁndings.
7. TRANSTHORACIC ECHOCARDIOGRAPHY IN
OUTPATIENT PEDIATRIC CARDIOLOGY:
APPROPRIATE USE CRITERIA (BY INDICATION)Appropriate Use Rating
ons
ase, a benign family history, and no recent ECG R (2)
ase, a benign family history, and a normal ECG R (1)
M (6)
R (3)
M (4)
0 years) of sudden cardiac arrest or death A (7)
A (9)
A (9)
ings
R (3)
R (3)
A (7)
M (6)
M (6)
A (9)
R (2)
R (1)
.
¼ electrocardiogram; PACs ¼ premature atrial contractions; PVCs ¼ premature ven-
Appropriate Use Rating
R (3)
e, a benign family history, and a normal ECG R (2)
A (7)
M (5)
years) of sudden cardiac arrest or death and/or A (9)
A (9)
R (2)
M (4)
A (9)
A (7)
R (2)
.
¼ Electrocardiogram.
TABLE 4 Murmur
Indication Appropriate Use Rating
39. Presumptively innocent murmur with no symptoms, signs, or ﬁndings of cardiovascular disease and a benign
family history
R (1)
40. Presumptively innocent murmur with signs, symptoms, or ﬁndings of cardiovascular disease A (7)
41. Pathologic murmur A (9)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram.
TABLE 5 Other Symptoms and Signs
Indication Appropriate Use Rating
42. Symptoms and/or signs suggestive of congestive heart failure, including but not limited to respiratory distress,
poor peripheral pulses, feeding difﬁculty, decreased urine output, edema, and/or hepatomegaly
A (9)
43. Chest wall deformities and scoliosis pre-operatively M (6)
44. Fatigue with no other signs and symptoms of cardiovascular disease, a normal ECG, and a benign family history R (3)
45. Signs and symptoms of endocarditis in the absence of blood culture data or a negative blood culture A (8)
46. Unexplained fever without other evidence for cardiovascular or systemic involvement M (5)
47. Central cyanosis A (8)
48. Isolated acrocyanosis R (1)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram.
TABLE 3 Chest Pain
Indication Appropriate Use Rating
28. Chest pain with no other symptoms or signs of cardiovascular disease, a benign family history, and a normal ECG R (2)
29. Chest pain with other symptoms or signs of cardiovascular disease, a benign family history, and a normal ECG M (6)
30. Exertional chest pain A (8)
31. Non-exertional chest pain with no recent ECG R (3)
32. Non-exertional chest pain with normal ECG R (1)
33. Non-exertional chest pain with abnormal ECG A (7)
34. Chest pain with family history of sudden unexplained death or cardiomyopathy A (8)
35. Chest pain with family history of premature coronary artery disease M (4)
36. Chest pain with recent onset of fever M (6)
37. Reproducible chest pain with palpation or deep inspiration R (1)
38. Chest pain with recent illicit drug use M (6)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram.
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TABLE 7 Systemic Disorders
Indication Appropriate Use Rating
62. Cancer without chemotherapy M (5)
63. Prior to or during chemotherapy in cancer A (8)
64. Sickle cell disease and other hemoglobinopathies A (8)
65. Connective tissue disorder such as Marfan, Loeys Dietz, and other aortopathy syndromes A (9)
66. Suspected connective tissue disorder A (7)
67. Clinically suspected syndrome or extracardiac congenital anomaly known to be associated with congenital heart disease A (9)
68. Human immunodeﬁciency virus infection A (8)
69. Suspected or conﬁrmed Kawasaki disease A (9)
70. Suspected or conﬁrmed Takayasu arteritis A (9)
71. Suspected or conﬁrmed acute rheumatic fever A (9)
72. Systemic lupus erythematosis and autoimmune disorders A (7)
73. Muscular dystrophy A (9)
74. Systemic hypertension A (9)
75. Renal failure A (7)
76. Obesity without other cardiovascular risk factors R (2)
77. Obesity with obstructive sleep apnea M (6)
78. Obesity with other cardiovascular risk factors M (6)
79. Diabetes mellitus R (3)
80. Lipid disorders R (3)
81. Stroke A (8)
82. Seizures, other neurologic disorders, or psychiatric disorders R (2)
83. Suspected pulmonary hypertension A (9)
84. Gastrointestinal disorders, not otherwise speciﬁed R (2)
85. Hepatic disorders M (4)
86. Failure to thrive M (5)
87. Storage diseases, mitochondrial and metabolic disorders A (8)
88. Abnormalities of visceral or cardiac situs A (9)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate.
TABLE 6 Prior Test Results
Indication Appropriate Use Rating
49. Known channelopathy M (4)
50. Genotype positive for cardiomyopathy A (9)
51. Abnormal chest X-ray ﬁndings suggestive of cardiovascular disease A (9)
52. Abnormal ECG without symptoms A (7)
53. Desaturation based on pulse oximetry A (9)
54. Previously normal echocardiogram with no change in cardiovascular status or family history R (1)
55. Previously normal echocardiogram with a change in cardiovascular status and/or a new family history suggestive of
heritable heart disease
A (7)
56. Elevated anti-streptolysin O titers without suspicion for rheumatic fever R (3)
57. Chromosomal abnormality known to be associated with cardiovascular disease A (9)
58. Chromosomal abnormality with undeﬁned risk for cardiovascular disease M (5)
59. Positive blood cultures suggestive of infective endocarditis A (9)
60. Abnormal cardiac biomarkers A (9)
61. Abnormal barium swallow or bronchoscopy suggesting vascular ring A (7)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram.
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TABLE 8
Family History of Cardiovascular Disease in Patients Without Signs or Symptoms and Without Conﬁrmed
Cardiac Diagnosis
Indication Appropriate Use Rating
89. Unexplained sudden death before the age of 50 years M (6)
90. Premature coronary artery disease before the age of 50 years R (2)
91. Channelopathy R (3)
92. Hypertrophic cardiomyopathy A (9)
93. Non-ischemic dilated cardiomyopathy A (9)
94. Other cardiomyopathies A (8)
95. Unspeciﬁed cardiovascular disease R (3)
96. Disease at high risk for cardiovascular involvement, including but not limited to diabetes, systemic hypertension,
obesity, stroke, and peripheral vascular disease
R (2)
97. Genetic disorder at high risk for cardiovascular involvement A (7)
98. Marfan or Loeys Dietz syndrome A (7)
99. Connective tissue disorder other than Marfan or Loeys Dietz syndrome M (6)
100. Congenital left-sided heart lesion, including but not limited to mitral stenosis, left ventricular outﬂow tract
obstruction, bicuspid aortic valve, aortic coarctation, and/or hypoplastic left heart syndrome
M (6)
101. Congenital heart disease other than the congenital left-sided heart lesions M (5)
102. Idiopathic pulmonary arterial hypertension M (5)
103. Heritable pulmonary arterial hypertension A (8)
104. Pulmonary arterial hypertension other than idiopathic and heritable R (3)
105. Consanguinity R (3)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate.
TABLE 9 Outpatient Neonates Without Post-Natal Cardiology Evaluation
Indication Appropriate Use Rating
106. Suspected cardiovascular abnormality on fetal echocardiogram A (9)
107. Isolated echogenic focus on fetal ultrasound R (2)
108. Maternal infection during pregnancy or delivery with potential fetal/neonatal cardiac sequelae A (7)
109. Maternal diabetes with no prior fetal echocardiogram M (6)
110. Maternal diabetes with a normal fetal echocardiogram M (4)
111. Maternal phenylketonuria A (7)
112. Maternal autoimmune disorder M (5)
113. Maternal teratogen exposure M (6)
The number in parenthesis next to the rating reﬂects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate.
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20508. FLOW DIAGRAMS FOR COMMON
PATIENT SYMPTOMSFIGURE 3 Chest Pain
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication.
*See Discussion section. Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram.
FIGURE 4 Syncope
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram; ICD ¼ Implantable Cardioverter Deﬁbrillator.
FIGURE 5 Palpitations and Arrhythmias
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication.
*See Discussion section. Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram; ICD ¼ Implantable
Cardioverter Deﬁbrillator; PACs ¼ Premature Atrial Contractions; PVCs ¼ Premature Ventricular Contractions.
FIGURE 6 Murmur
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate.
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This is the ﬁrst report by the American College of Cardi-
ology addressing appropriate use in the ﬁeld of pediatric
cardiology. Although the use of AUC for various areas of
cardiovascular imaging in adult cardiology has been
established since 2005, there has not been a tool to
guide practice in pediatric cardiology (1,18). Given the
high level of utilization of echocardiography in the
outpatient setting, this topic was chosen as the subject
for the ﬁrst pediatric AUC, and was intentionally
restricted to initial, outpatient, and transthoracic echo-
cardiographic evaluation. Of the various diagnostic mo-
dalities, echocardiography remains the most readily
available, non-invasive and highly diagnostic tool for
assessing cardiac structure, function and hemodynamics
in those with suspected cardiac disease. This report will
help us establish the infrastructure precedent for
expanding AUC for echocardiography in pediatric pa-
tients as well as AUC for other diagnostic modalities and
procedures used in this ﬁeld.
It is important to note the differences between clinical
practice guidelines and AUC (19). The American College of
Cardiology guidelines have been developed by leaders in
the ﬁeld of cardiovascular medicine using evidence-
based documents and expert opinion and are in general
quite broad. Even though AUC are evidence based,
they are created around possible clinical scenarios
that are encountered in everyday practice rather than
starting with options based on current evidence.
Echocardiography is the most common imaging modality
used in cardiology, but there is evidence that it may not
be a cost-effective or high-yield diagnostic test for some
indications included in this document (20–29). The AUC
address a reasonable role of echocardiography. Each
individual patient is unique and the possible use of
echocardiography deserves to be considered in full
clinical context. It is noteworthy that there are no recent
practice guidelines for indications of echocardiography
in pediatric patients and this report may become a
clinically useful guide for practitioners (30).
Assumptions and Deﬁnitions
Some of the assumptions used while writing this report
are important to emphasize. It is assumed that a thor-
ough history and physical examination has been per-
formed by a qualiﬁed clinician and that use of other
more diagnostic tests has been considered prior to
ordering an echocardiogram. It is also assumed that the
echocardiogram is performed and interpreted by quali-
ﬁed individuals. Although the AUC ratings listed in this
report provide general guidance for when transthoracic
echocardiography may be useful in a speciﬁc patient
population, the role of clinical judgment in ordering thetest for an individual patient should not be undermined
because there may be reasons other than those listed in
this document that preclude application of the AUC. The
AUC may also not be applicable if another diagnostic
modality has already proven the diagnosis for which an
echocardiogram was intended. For example, if a vascular
ring is conﬁrmed by cardiac magnetic resonance imaging
(MRI), then an echocardiogram will not provide any
additional critical information. Even though this indica-
tion is rated as Appropriate in this document, clinical
judgment in such scenarios will deﬁnitely supersede the
AUC rating.
The deﬁnitions provided in this document were ﬁnal-
ized by the writing group after it had given due consid-
eration to the current literature and views provided by the
external reviewers and the rating panel. The users of this
document should be well versed in these assumptions
and deﬁnitions prior to implementing the AUC.
Indications and Ratings
The indications presented in this report were ﬁnalized
after incorporating the suggestions by the external re-
viewers, and the members of the rating panel rated the
indications independently. The median score for each
indication became the ﬁnal rating. In general, the in-
dications rated as Appropriate included evaluation of
new cardiac symptoms or clinical scenarios known to be
associated with congenital or acquired heart disease in
the pediatric population. The indications ranked as
Rarely Appropriate clustered around broad systemic
diseases and family history of conditions that are
generally not known to be associated with structural or
functional abnormalities detectable by echocardiogra-
phy. Scenarios that were rated as May Be Appropriate, in
general, involved uncertainty or required additional
clinical information to better deﬁne the appropriateness
of the test.
In the pediatric population, chest pain, syncope and
murmur are 3 common reasons for referral of an echo-
cardiogram in the outpatient setting. For this reason,
tables dedicated to each of these conditions with various
clinical scenarios were included in the current report.
Although a murmur is one of the most common indica-
tions for obtaining an echocardiogram in the pediatric
population, it is well known that a large number of pa-
tients are referred with an innocent murmur that does
not require evaluation with an echocardiogram. The
current document presumes that the clinician has made
every effort to determine whether the murmur is inno-
cent or not prior to considering the use of an echocar-
diogram (21,31). Echocardiographic screening for
presumably or clearly innocent murmur has been rated as
Rarely Appropriate in this document. This rating is sup-
ported by prior publications reporting that examination
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tinguishing between innocent and pathologic murmurs
(21,32,33). Pathologic murmurs (including those that are
not clearly innocent after evaluation), along with pre-
sumably innocent murmurs with other signs, symptoms
or ﬁndings of cardiovascular disease, were found to be
Appropriate for an echocardiogram, since these situa-
tions suggest the possibility of a cardiovascular abnor-
mality as their underlying cause. Of course, the ability to
make a ﬁnal diagnosis of innocent murmur after an
echocardiogram for patients meeting either of these
appropriate indications does not imply that the rationale
for using an echocardiogram to rule out a cardiovascular
abnormality was not appropriate.
Chest pain and syncope are 2 other common pre-
sentations in the pediatric age group. The etiology for
these is generally benign and echocardiography has
been shown to be low-yield, unlike in adult patients
(25–29). For this reason, the indications and their ratings
related to chest pain in this document are very different
from those in the adult AUC. Syncope with no other
symptoms or signs of cardiac disease has been rated as
Appropriate in the adult AUC (3), but rated as Rarely
Appropriate for pediatric patients (Indication #18),
albeit with additional qualiﬁers of a benign family
history and a normal ECG. The reasonableness of using
an echocardiogram as a primary screen versus using an
echocardiographic assessment only after a pediatric
cardiology consultation for evaluation of a murmur, chest
pain, syncope, or any other indication, depends on many
factors and needs to be given due consideration on a
case-by-case basis.
Given the complexity of clinical presentations, it is
likely that there will be some overlap between the in-
dications in this document. Several indications share
identical accompanying ﬁndings, signs or symptoms, but
differ as to the primary patient complaint. As such, the
ratings were driven in these scenarios by the prevalence
of the primary presentation and the likelihood of it being
cardiac-related. For example, non-exertional chest pain
with abnormal ECG (A [7] #33) and palpitations with
abnormal ECG (M [6] #3) have been rated slightly
differently by the panel even though they both relate to
an abnormal ECG. Given the broad deﬁnition of an
abnormal ECG described in this paper, it is not unex-
pected that the ratings for palpitations that may
accompany more benign ECG ﬁndings were a bit lower.
Similarly, ratings for indications related to symptoms
or signs of cardiovascular disease changed slightly
depending on other presenting factors described in the
scenarios (#29 – chest pain and signs and symptoms – M
[6], #40 – presumptively innocent murmur with signs
and symptoms – A [7], and #42 – congestive heart failure
with signs and symptoms – A [9]). In applying the AUC, ifmore than one indication listed in this document could
be applied, clinicians need to use their judgment in
picking the scenario that most closely ﬁts the individual
patient.
Comparison With the Adult Cardiology AUC
The current adult cardiology AUC for echocardiography
includes initial and follow-up evaluation in the inpatient
and outpatient setting using transthoracic, trans-
esophageal, and stress echocardiography (3). In contrast,
this current document is limited to initial outpatient
transthoracic echocardiography. The initial adult car-
diology AUC for transthoracic and transesophageal
echocardiography were published in 2007 (1). After
practical application of these AUC, a revised version was
published in 2011. This revised version which is currently
in use included many more indications and now provides
a more complete range of clinical scenarios (3). Studies
comparing the application of these two AUC in adult
cardiology clinical practice have demonstrated signiﬁcant
improvement in the ability to classify the various clinical
scenarios using the revised version (34,35). This current
report for pediatric patients has certainly beneﬁted from
the maturational process and experience gained by the
AUC in adults (36). Implementation studies in the
pediatric population will help us to identify any missing
or ambiguous indications that could be addressed in
future revisions.
In comparing the ratings of various indications in
the current document with those in the adult AUC, there
were many indications that were rated similarly (3).
For example, isolated PACs and sinus bradycardia
were rated as Rarely Appropriate indications in both
documents, while SVT, VT, pathologic murmurs, initial
evaluation of suspected pulmonary hypertension, sys-
temic hypertension, and suspected endocarditis were
rated as Appropriate in both. However, there were some
striking differences in the ratings of some indications
such as syncope and chest pain due to variations in the
most common underlying causes in pediatric versus adult
patients.
There are also differences in format. In this report,
prior test results for which a subsequent echocardiogram
may be ordered are listed separately in Table 7 with
individual ratings; but in the adult AUC report they are
lumped together under one indication (‘Prior testing
that is concerning for heart disease or structural
abnormality including but not limited to chest X-ray,
baseline scout images for stress echocardiogram, ECG, or
cardiac biomarkers’ (3)), and are rated as Appropriate.
The current report also includes a broad list of systemic
disorders (Table 7) and scenarios related to family
history (Table 8) that are not covered in the adult AUC
report.
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The current AUC report is not fully inclusive of all
possible clinical scenarios and does not include in-
dications for follow-up or inpatient echocardiography. In
addition, it is restricted to the ﬁrst use of transthoracic
echocardiography and does not include indications for
fetal or transesophageal echocardiography. Some of the
indications have been purposefully kept broad either
because it was beyond the scope of this report to list each
and every possible scenario, or because they were
considered fairly uncommon in routine practice. Exam-
ples of these broad indications include use of illicit drugs,
chest wall deformities, chromosomal abnormalities with
undeﬁned risk of cardiovascular disease, suspected con-
nective tissue disorders, neurologic or psychiatric disor-
ders, gastrointestinal and hepatic disorders and several
indications related to family history.
Though we have attempted to cover a broad range of
clinical scenarios in this document, we realize that by no
means is this list exhaustive. Given the experience with
the adult cardiology AUC, it would not be surprising for us
to have missed some common indications. We also
recognize that this document does not address the
appropriateness, or lack thereof, of not performing echo-
cardiograms. This underutilization of echocardiography
could result from a lack of availability (equipment, so-
nographer or interpreting cardiologist), denial by payers
or lack of insurance, alteration of the management plan
following expert consultation, or lack of sound clinical
judgment.
Use of AUC to Improve Care
We foresee several important applications of these AUC in
the pediatric population. The most obvious use of this
document will be to support the clinical decision making
of a provider as to the appropriateness of care that they
deliver to an individual pediatric patient. It is important
to keep in mind that an Appropriate rating in this docu-
ment should not be misinterpreted as a recommendation
to perform an echocardiogram in every patient that meets
the indications described herein. Rather, it should be
interpreted as something that would be reasonable to do
if the information obtained will help in caring for the
patient. On the other hand, a Rarely Appropriate rating
should not be misinterpreted as one in which an echo-
cardiogram should absolutely not be performed. This
category was termed as “Inappropriate” in the initial AUC
documents, but due to signiﬁcant misperceptions, the
AUC Task Force changed the terminology from Inappro-
priate to Rarely Appropriate to emphasize that individual
patient circumstances do exist where an echocardiogram
would be reasonable to perform. Instead of precluding an
echocardiogram in an individual patient, the importanceof this category lies more in recognition of a pattern of
ordering where a signiﬁcantly higher number of echo-
cardiograms are requested for the Rarely Appropriate in-
dications by an individual provider compared with their
peers. Indications rated as May Be Appropriate could be
considered reasonable for obtaining an echocardiogram,
particularly if the physician taking care of the patient
determines that it would provide helpful information.
These two categories should not be considered as the
basis for denying insurance coverage or reimbursement
for the procedure, as individual decision making is
required to determine what is best for each patient.
Nevertheless, it is important for the clinicians taking care
of pediatric patients to recognize that healthcare facil-
ities, accreditation bodies, or payers for these tests may
use this document to ensure quality care and appropriate
use of ﬁnancial resources.
Ideally, this document will also serve as an educational
and quality improvement tool for addressing the high
number of Rarely Appropriate referrals for echocardio-
grams by individual providers. Experience with the
adult echocardiography AUC has shown that physician
engagement in quality improvement programs, and
tracking and benchmarking of test ordering behavior, has
reduced the percentage of inappropriate testing (37).
Further, lab accreditation organizations such as the
Intersocietal Accreditation Commission (IAC) require
attention to AUC as part of their quality improvement
process (38). Finally, the AUC may provide the basis for
evaluation of the impact of using AUC, especially as
accessed by online tools, instead of more onerous
and less physician-driven administrative controls on
imaging use.10. CONCLUSIONS
This AUC report provides a helpful guide to clinicians in
determining the reasonable role of initial transthoracic
echocardiography in the evaluation of pediatric patients
in an outpatient setting. It also lays the foundation for
developing AUC in other areas of pediatric cardiology.
Furthermore, it can form the basis of designing educa-
tional and quality improvement projects to improve
quality of care. Future studies to evaluate implementa-
tion of these AUC in clinical care will be helpful not only
in identifying any deﬁciencies in the current document,
but also in deﬁning ordering patterns for individual
practitioners and understanding variations in delivery of
care. We expect that there will be a continued need for
reﬁnement of these AUC based on any gaps identiﬁed
through this initial effort, changes in evidence-based
medicine, and availability of technical and ﬁnancial
resources.
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